Commentary: Not Only Safety but Also Efficacy is Required in Repeat Pulmonary Resection for Second Non–small Cell Lung Cancer

Ke-Neng Chen

DOI: https://doi.org/10.1016/j.jtcvs.2020.08.009

2021-01-01

Abstract:Main limitations of the present article include selection bias, which are unavoidable when considering a retrospective study like this, and the limited statistical sample, although few similar series have been reported in the literature so far, with most of published data referring to second contralateral tumors. 5 Comparison with patients undergoing stereotactic body radiation therapy is often considered as a crucial point to assess the role of reoperations for ipsilateral metachronous lung cancer.However, caution should be used when comparing results of stereotactic body radiation therapy, especially because series of patients undergoing irradiation have not had pathological staging and have variable inclusion criteria, sometimes without a conclusive histologic diagnosis. 4,6 Anatomic parenchymal-sparing re-resection seems a promising route in this clinical setting.However, the benefit of sparing lung parenchyma with respect to CP may appear questionable in some particular cases, as that reported by Hattori and colleagues 1 of a right lower lobectomy after previous ipsilateral upper lobectomy, leaving only the residual middle lobe.Therefore, further specific evaluation for each type of anatomic operation will be necessary to provide more precise and thorough indications for such interventions.